Society for Neuroscience - Search

Skip Navigation

  • join logo Join
  • give logo Give
  • advocate logo Advocate
  • publish logo Publish
  • Icon with thought bubbles Learn
Shop Sign In
SfN Logo 2025
  • Membership
    • Learn About Membership
      • Individual Member Benefits
      • Institutional Program Member Benefits
      • Sustaining Associate Member Benefits
      • Get Involved at SfN
    • Become a Member
      • Sponsorship Information for New Members
      • Membership Categories & Fees
      • Membership Fees for Developing Countries
      • Renew Individual Membership
    • Member Resources
      • Automatic Renewals
      • Frequently Asked Questions
      • Individual Member Directory
      • Member Obituaries and Memorial Donations
    • Learn About Local Chapters
      • Start or Reactivate a Chapter
      • Resources for Chapters
      • Submit Annual Report
      • Chapter Directory
      • Frequently Asked Questions
  • Meetings
    • Meetings Overview
    • Neuroscience 2025
      • Call for Abstracts
      • Sessions and Events
      • Registration
      • Housing and Travel
      • Exhibits
      • Dates and Deadlines
      • Advertising and Sponsorship
      • FAQs
    • Global Events
      • SfN Virtual Events
    • Past and Future Annual Meetings
      • Neuroscience 2024
      • Neuroscience 2023
      • Search Past Annual Meeting Abstracts
      • Attendance Statistics
    • Meeting Policies and Guidelines
      • Code of Conduct at SfN Events
      • Guidelines for Participating in SfN Events
      • Photography & Recording Policy
      • Presenter Guidelines and Policies for SfN Events
    • Meeting Awards
      • Trainee Professional Development Award
      • International Travel Awards
      • FENS Member Awards to SfN Annual Meeting
      • IBRO Member Awards to SfN Annual Meeting
      • JNS Member Awards to SfN Annual Meeting
  • Careers
    • Careers Overview
    • Institutional Program (IP) Directory
    • NeuroJobs Career Center
      • Job Seekers
      • Employers
    • 2025 Graduate School Fair
    • Career Tools and Resources
      • Neuronline
      • Neurobiology of Disease Workshop
      • Responsible Conduct of Research Short Courses
      • Global Funding Sources
    • Higher Education and Training
      • Core Competencies
      • Neuroscience Training Program Survey
    • Awards
      • Outstanding Career and Research Achievements
      • Early Career
  • Initiatives
    • Initiatives Overview
    • Awards
      • 2024 Award Recipients
      • Awards and Prizes FAQ
      • Trainee Professional Development Award
    • Neuroscience Scholars Program
    • Neuronline
      • Attend
      • Read
      • Watch
      • Listen
      • Collections
    • Resources to Stay Connected
      • SfN Zoom Backgrounds
    • Diversity Initiatives
    • Women and Neuroscience
      • Increasing Women in Neuroscience (IWiN) Courses & Toolkit
      • Celebration of Women in Neuroscience Event
      • Awards
    • Animals in Research
      • Support for Members and Institutions
      • Tools and Resources
      • Resources for Medical Students
    • Public Education Programs
      • Resources for Educators
      • Brain Awareness Video Contest
      • Life of a Neuron Exhibit
  • Advocacy
    • Advocacy Overview
    • Advocacy Response
    • Advocacy Network
      • The NeuroAdvocate Challenge
      • Advocacy Action Center
      • Advocacy Best Practices
      • Advocacy Network News
      • Advocacy Training Seminars
    • US Advocacy Programs
      • Capitol Hill Day
      • Connect with Policymakers
      • Early Career Policy Ambassadors
      • Partner with a Local Chapter
      • Engage the Media
    • Global Advocacy Programs
      • Global Neuroscience Initiatives
      • Global Funding
      • North American Programs
    • Science Funding
      • Advocacy Videos
      • Advocacy Resources
      • US Neuroscience Initiatives
      • Funding Priorities and Processes
    • Policy Positions
      • Statements and Testimony
      • Sign-On Letters
  • Outreach
    • Outreach Overview
    • BrainFacts.org
    • Find a Neuroscientist
    • Brain Awareness Campaign
      • Webinar: The ABC's of BAW
      • How to Get Involved
    • Awards
      • Award for Education in Neuroscience
      • Next Generation Award
      • Chapter of the Year Award
      • Science Educator Award
  • Publications
    • Publications Overview
    • SfN News
    • JNeurosci
    • eNeuro
    • SfN Nexus
    • Neuroscience Quarterly
    • Annual Report
    • History of Neuroscience Autobiographical Chapters
  • About
    • About Overview
    • Mission and Strategic Plan
    • What We Do
      • Annual Report
      • Bylaws
      • Resolutions to the Bylaws
      • Environmental Commitment
      • Strategic Partners
      • History of SfN
    • SfN 50th Anniversary Celebration
    • NIH Public Health Service-Supported Funding Financial Conflict of Interest Policy
    • Volunteer
      • SfN Council
      • SfN Presidents
      • Committees
      • Elections
      • Call for Nominations
    • Professional Conduct
      • SfN Ethics Policy
      • Guidelines for Responsible Conduct Regarding Scientific Communication
      • Code of Conduct at SfN Events
      • Commitment to Scientific Integrity
      • Neuronline Digital Learning Community Guidelines
    • History of Neuroscience
      • Autobiographical Chapters
      • Autobiographical Videos of Prominent Neuroscientists
      • Classic Papers
      • Neuroscience History Resources
      • Robert Doty's Chapter on Neuroscience
    • Careers and Staff
      • Staff List
  1. Search

Filter

  • (2)
  • (1)
  • (3)
  • (6)
  • (8)
  • (1)
  • (574)
  • (3)
  • (2)
  • (8)
Filter
81 - 90 of 890 results
  • Abstract
    Cannabidiol modulates behavioral and gene expression alterations induced by spontaneous heroin withdrawal
    Background: Previous clinical data suggest that cannabidiol (CBD), a non-psychoactive constituent of the Cannabis sativa plant with anxiolytic, antidepressant, antipsychotic properties, and anti-addictive properties, may hold promise as a therapeutic to...
    Nov 9, 2021
  • Abstract
    Anxiolytic effects of full-spectrum cannabidiol-rich hemp extracts in mice
    Cannabidiol (CBD) is a non-intoxicating cannabinoid that has been shown to have anxiolytic properties. There is a vast number of CBD products available to potential users, yet many pre-clinical empirical assessments of CBD’s efficacy are limited by the ...
    Oct 23, 2019
  • Abstract
    Cannabidiol potentiates ethanol consumption in rats exposed to ethanol vapor chamber
    Drug abuse reached considerable proportions in the last years. Studies have shown that cannabidiol (CBD) has anxiolytic, anti-psychotic, antidepressant and neuroprotective properties. There are also evidence that CBD can reduce drug-seeking behavior. De...
    Nov 7, 2018
  • Abstract
    Gender-dependent effects of cannabidiol on ethanol binge drinking in mice
    Binge drinking has become a major public health concern due to its high prevalence in modern societies and the scarce and limited pharmacological options available for its clinical management. In this sense, cannabidiol (CBD) has been recently proposed ...
    Nov 7, 2018
  • Abstract
    Tetrahydrocannabinol-induced hypernausea assessed in the conditioned gaping model in rats
    The psychoactive component of cannabis, Δ9-tetrahydrocannabinol (THC), is known to produce several aversive effects in human users and experimental animals. THC is a partial agonist of the cannabinoid 1 (CB1) receptor of the endocannabinoid (eCB) system...
    Nov 6, 2018
  • Abstract
    Paternal THC exposure in rats impacts neurobehavioral effects in the offspring
    Developmental neurotoxicity with maternal exposure during gestation is very well established for a wide variety of toxicants. In contrast, the effects of paternal exposure on offspring neurotoxicity is much less well studied. Preconception exposure to t...
    Nov 4, 2018
  • Abstract
    Dissection of the tau gene haplotype association with PSP, CBD, and AD.
    We aimed to establish the pathogenic basis of the association of the tau gene, MAPT, H1 haplotype with progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD). EM analysis of HapMap SNP data for MAPT, showed considerable diversity of the H1 clade with 21 rare (<5%) and 3 common (>10%) haplotypes. Only one of the latter represents H2. We then typed a set of 6 haplotype-tagging SNPs (htSNPs) capturing most of this diversity, in large PSP and CBD case-control cohorts of UK and US origin. We confirmed the strong association with PSP of the H1 haplotype (UK PSP: p=1.14x10-5; US PSP: p=4.02x10-8). In PSP we identified differences in association of the H1H1 genotype between Richardson’s syndrome, RS (OR 13.2; 95%CI 3.0-57.2; p<0.001) and PSP-parkinsonism, PSP-P (OR 4.5; 95%CI 1.3-16.0; p=0.018)1. The H2 haplotype is negatively associated, ie is protective (UK PSP: p=1.1x10-5; US PSP: p=4.02x10-8). The H1-specific htSNPs, rs242557 and rs2471738, are highly associated with PSP and CBD (UK PSP: p=0....
    Nov 16, 2005
  • Abstract
    EFFECTS OF MARIJUANA ON NEUROPHYSIOLOGICAL CORRELATES OF WORKING AND INTERMEDIATE-TERM MEMORY.
    Cannabinoid receptors are abundant in the frontal cortex and hippocampus, areas crucial for attentional control, working memory (WM), and the creation of more lasting memories. Although knowledge of marijuana's neurobiological effects has proliferated, research on marijuana's impact on human cognitive brain function has not progressed as quickly. To examine marijuana’s effects on neurophysiological measures of working and recent memory, a double-blind, counterbalanced study was performed in which 40-channel EEG recordings were obtained from N=10 casual marijuana users before and after smoking active (3.45% THC) or placebo (0.006% THC) marijuana. A spatial N-back task was used to measure WM ability. Intermediate-term memory over a period of 5-10 minutes was measured with a word recognition task. Objective and subjective measures of intoxication increased after smoking marijuana, but alertness and motivation were unchanged. After smoking marijuana reaction time in the WM task increased, as did EEG alpha (8-1...
    Nov 13, 2001
  • Abstract
    Effects of frequent marijuana use on attention-related regional cerebral blood flow.
    Whether chronic marijuana (MJ) use adversely affects human brain function remains controversial. Using [15O] water PET, regional cerebral blood flow during selective attention was compared in R-handed MJ users (9 M, 9 F; mean ± SD age, 22.3 ± 2.2 y) and controls (6 M, 7 F; 22.6 ± 1.9 y). The users had been using MJ ≥7 times weekly on average for ≥2 y (mean, 3.9 ± 1.8 y). The controls had never or rarely used MJ. Following MRI, and after ≥26 h of monitored abstention, subjects performed dichotic listening tests using nonsense word stimuli while being imaged with PET. The tests were modifications of previous ones used by our group (O'Leary et al. (1996) Brain Lang 53: 20-39). During separate tests, attention was directed to the L and R ears. A control test, choice reaction time (missing for 2 subjects), was used to control for auditory stimulation and motor responses. Within group subtractions of the control test from the attention tests showed major attention-related activations in auditory cortex, i.e., su...
    Nov 8, 2000
  • Abstract
    Cannabidiol treatment induces antidepressant-like effect in streptozotocin-induced diabetic rats
    Depression is highly incident in the diabetic patients. It is known that several antidepressant drugs used to treat depression may alter the blood glucose or even interact with hypoglycemic drugs. Thus, the search for a more effective treatment for the ...
    Nov 14, 2017
  • Previous
  • 7
  • 8
  • 9
  • 10
  • 11
  • Next

Featured

  • Watch: The Inspiration Behind the Neuroscience 2025 Logo
  • Upcoming Webinar: JNeurosci Town Hall
  • Find a Roommate for Neuroscience 2025 in the Roommate Matching Forum
SfN Websites
  • BrainFacts.org logo
  • eNeuro logo
  • JNeurosci logo
  • Neuronline logo
Engage with SfN
  • join Join
  • give Give
  • advocate Advocate
  • publish Publish
Quick Links
  • SfN News
  • For Press
  • Global Events
  • Contact Us
  • Advertise
  • Code of Conduct
  • Jobs at SfN
  • SfN Store
  • Social Media
Follow SfN
  • BlueSky logo
  • Facebook logo
  • Instagram logo
  • LinkedIn logo

  • Threads logo
  • X Logo
  • YouTube logo
SfN logo with "SfN" in a blue box next to Society for Neuroscience in red text and the SfN tag line that reads "Advancing the understanding of the brain and nervous system"
1121 14th Street NW, Suite 1010, Washington, D.C. 20005
(202) 962-4000 | 1-888-985-9246
  • Accessibility Policy
  • Disclaimer
  • Privacy Notice
  • Contact Us

Copyright ©
Society for Neuroscience